Sandra Zazo

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Journal: Molecular diagnosis & therapy

Published: December 22, 2025

Homologous recombination deficiency tumor tissue testing in a real-world cohort of tubo-ovarian carcinoma patients: validation of decentralized genomic profiling in 4777 cases.

Homologous recombination deficiency tumor tissue testing in a real-world cohort of tubo-ovarian carcinoma patients: validation of decentralized genomic profiling in 4777 cases.

Journal: Virchows Archiv : an international journal of pathology

Published: December 13, 2025

Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Journal: Oncogene

Published: August 06, 2025

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era.

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era.

Journal: Cancer treatment and research communications

Published: March 31, 2025

Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer.

Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancer.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 13, 2025

Exercise and tumor proteome: insights from a neuroblastoma model.

Exercise and tumor proteome: insights from a neuroblastoma model.

Journal: Physiological genomics

Published: September 23, 2024

Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain.

Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain.

Journal: Cancer medicine

Published: August 14, 2023

Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.

Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.

Journal: Exercise immunology review

Published: June 26, 2023

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.

Journal: Cancers

Published: December 26, 2022

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.

Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.

Journal: Cancers

Published: October 17, 2022

Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Journal: International journal of molecular sciences

Published: September 26, 2022

MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.

MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.

Journal: International journal of molecular sciences

Published: September 16, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026